
    The New York Times
Mike McIntire
9:45 pm
"Fact Check: Gingrich the Lobbyist?"
But he did many of the same things lobbyists do, including meeting with state lawmakers, members of Congress and federal officials to promote issues important to companies that were paying his consulting firm as much as $200,000 a year.
His dealings with drug maker Novo Nordisk show how his work could easily be viewed as lobbying. The Danish company paid Mr. Gingrich to help expand the market for its diabetes treatments in the United States.
But in its annual report to shareholders, Novo Nordisk offered a different take. It listed Mr. Gingrich's work for the company under the category of public-policy activities, noting: "Such activities are often referred to as lobbying."
  